Gobernanza STAAR Surgical Company

STAA

US8523123052

Equipo médico, suministros y distribución

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 24/01/2025			Varia. Cinco días.	Varia. 1 de enero.
24,45 ^USD	+2,09 %		+9,69 %	+0,66 %

05/11	Tarsus Pharmaceuticals, Inc. nombra a Elizabeth Yeu directora médica	CI
30/10	STAAR Surgical Company, Q3 2024 Earnings Call, Oct 30, 2024

Comité Ejecutivo: STAAR Surgical Company

Director

Funciones ocupadasDesde

Thomas Frinzi

69 años

Chief Executive Officer	01/01/2023
President	01/01/2023

Keith Holliday

62 años

Chief Tech/Sci/R&D Officer

19/08/2015

Scott Barnes

63 años

Chief Tech/Sci/R&D Officer

01/10/2017

Brian Moore

Investor Relations Contact	-
Public Communications Contact	-

Patrick Williams

52 años

Director of Finance/CFO

06/07/2020

Magda Michna

49 años

Chief Tech/Sci/R&D Officer	01/04/2023
General Counsel	01/04/2023

Warren Foust

49 años

Chief Operating Officer

24/04/2023

Nathaniel Sisitsky

51 años

General Counsel	01/12/2023
Corporate Secretary	01/12/2023

Composición del Consejo de Administración: STAAR Surgical Company

Administrador

ComitésDesde

Thomas Frinzi

69 años

Chairman

Aimee Weisner

56 años

Audit Committee	01/07/2014
Compensation Committee	01/02/2021
Governance Committee	16/06/2022
Nominating Committee	16/06/2022
Compensation Committee Chair	16/06/2022

Wei Jiang

61 años

Audit Committee	12/03/2024
Governance Committee Chair	12/03/2024
Nominating Committee Chair	12/03/2024

Stephen Farrell

60 años

Governance Committee	01/01/2016
Nominating Committee	01/01/2016
Audit Committee Chair	01/01/2016

Elizabeth Yeu-Lin

46 años

Audit Committee	21/01/2021
Compensation Committee	21/01/2021

Arthur Butcher

54 años

Compensation Committee

12/03/2024

Lilian Zhou

42 años

Audit Committee

Últimos Nombramientos: STAAR Surgical Company

Tarsus Pharmaceuticals, Inc. nombra a Elizabeth Yeu directora médica	05/11	CI
NEXGEL, Inc. nombra a Kip Crecca miembro de su Consejo Asesor Científico	04/10/24	CI
STAAR Surgical refuerza su equipo directivo con los nombramientos de Nancy Sabin como directora de marketing y Nathaniel Sisitsky como asesor general	01/05/24	CI
STAAR Surgical Company anuncia cambios en su junta directiva	12/03/24	CI
STAAR Surgical Company nombra a Lilian Zhou miembro de su Consejo de Administración	04/12/23	CI
STAAR Surgical nombra a Warren Foust director de operaciones	29/03/23	MT
STAAR Surgical Company anuncia nombramientos ejecutivos	29/03/23	CI

Más noticias

Antiguos Directivos y Administradores: STAAR Surgical Company

Insider

Funciones ocupadas

DesdeHasta

Kin Hung Yu

Director/Board Member	21/01/2021	20/06/2024
Independent Dir/Board Member	21/01/2021	20/06/2024

Gilbert Kliman

Director/Board Member	01/06/2020	01/12/2023
Independent Dir/Board Member	01/06/2020	01/12/2023

Denise McEachern

Corporate Officer/Principal

01/12/2014

29/03/2023

Caren Mason

Director/Board Member	01/06/2014	31/12/2022
Chief Executive Officer	01/03/2015	31/12/2022
President	01/03/2015	31/12/2022

Hans-Martin Blickensdoerfer

Chief Operating Officer	01/01/2005	-
Corporate Officer/Principal	08/12/2011	31/07/2022
Sales & Marketing	01/01/2005	08/12/2011

Louis Silverman

Director/Board Member	12/09/2014	-
Chairman	12/09/2014	01/01/2022
Independent Dir/Board Member	-	01/01/2022

John C. Moore

Director/Board Member	01/01/2008	24/06/2021
Independent Dir/Board Member	01/01/2008	24/06/2021

Jon K. Hayashida

Corporate Officer/Principal

23/07/2015

01/06/2021

Deborah Andrews

Comptroller/Controller/Auditor	01/09/2013	-
Director of Finance/CFO	28/04/2017	06/07/2020
Corporate Officer/Principal	01/01/1999	01/01/2001

William P. Wall

Director/Board Member	02/09/2015	03/05/2020
Independent Dir/Board Member	02/09/2015	03/05/2020

Stephen Brown

Comptroller/Controller/Auditor	09/09/2013	28/04/2017
Director of Finance/CFO	09/09/2013	28/04/2017

Charles P. Slacik

Director/Board Member	13/09/2012	01/09/2016
Independent Dir/Board Member	13/09/2012	01/09/2016

Randy Meier

Director/Board Member	26/06/2009	01/06/2016
Independent Dir/Board Member	01/06/2009	01/06/2016

Tony Kalajian

Director of Finance/CFO

01/07/2013

01/04/2016

Graydon Hansen

Chief Operating Officer

01/01/2016

Robin Hughes

Chief Tech/Sci/R&D Officer	06/09/2012	01/05/2015
Sales & Marketing	01/01/2007	06/09/2012

J. Steven Roush

Director/Board Member	21/04/2015	-
Independent Dir/Board Member	16/04/2015	-

Barry G. Caldwell

Director/Board Member	01/06/2011	01/03/2015
Chief Executive Officer	01/11/2007	01/03/2015
President	01/11/2007	01/03/2015

Dong Hong Chen

Chief Tech/Sci/R&D Officer

01/02/2013

01/12/2014

Kathryn A. Tunstall

Director/Board Member

30/01/2014

26/09/2014

Philippe Subrin

Corporate Officer/Principal

01/07/2014

Craig Felberg

Corporate Officer/Principal

01/01/2007

30/06/2014

Don Bailey

Director/Board Member	31/01/2014	01/06/2014
Chairman	28/04/2005	31/01/2014
Independent Dir/Board Member	28/04/2005	01/06/2014

David Choromanski

Sales & Marketing

15/05/2014

Donald Duffy

Director/Board Member	01/02/2003	-
Chief Operating Officer	22/05/2009	02/07/2010
Independent Dir/Board Member	01/02/2003	-

Samuel Gesten

Compliance Officer	05/04/2012	-
General Counsel	05/04/2012	-
Corporate Secretary	05/04/2012	-

Charles S. Kaufman

General Counsel	28/04/2005	05/04/2012
Corporate Secretary	28/04/2005	05/04/2012

David R. Morrison

Director/Board Member	01/05/2001	08/03/2012
Independent Dir/Board Member	01/05/2001	08/03/2012

Mark B. Logan

Director/Board Member	18/11/2010	31/01/2014
Chairman	31/01/2014	-
Independent Dir/Board Member	17/11/2010	-

David John Bailey

Director/Board Member	28/12/2000	27/08/2010
Chief Executive Officer	28/12/2000	01/11/2007
Chairman	28/12/2000	01/11/2007
Corporate Officer/Principal	28/12/2000	27/08/2010
President	28/12/2000	01/11/2007

Donald J. Todd

Corporate Officer/Principal

18/08/2010

William Walter Goodmen

Human Resources Officer

16/08/2010

Donald Lee Fagen

Sales & Marketing

02/02/2010

David L. Schlotterbeck

Director/Board Member

01/01/2005

30/10/2007

Robert Kenneth Lally

General Counsel

01/10/2006

Paul Hambrick

Chief Operating Officer	01/02/2006	08/12/2011
Corporate Officer/Principal	08/12/2011	-

John Bily

Director of Finance/CFO

28/04/2005

John Ross Gilbert

Director/Board Member

25/09/2004

Thomas R. Paul

Chief Tech/Sci/R&D Officer

01/01/2004

Nicholas Curtis

Sales & Marketing

01/08/2002

Volker D. Anhaeusser

Director/Board Member

01/01/2000

Thomas J. Chambers

Chief Tech/Sci/R&D Officer

01/01/2000

John S. Santos

Chief Tech/Sci/R&D Officer	21/05/2009	-
General Counsel	21/05/2009	-

Jesse Alvardo

Sales & Marketing

Joanne Egamino

Chief Tech/Sci/R&D Officer

Helene Lamielle

Chief Tech/Sci/R&D Officer

Steven L. Ziémba

General Counsel

Herbert Crane

Corporate Officer/Principal

Nicolay René Bérard-Andersen

Corporate Officer/Principal

Gerardo Lugo

Corporate Officer/Principal

Guenther Roepstrorff

President

James I. Farnworth

General Counsel

David W. Friess

Corporate Officer/Principal

Distribución por Edad de los Ejecutivos

Paridad de género

Hombre	13
Mujer	3

De los cuales Comité Ejecutivo

Hombre	8
Mujer	0

De los cuales Directores

Hombre	5
Mujer	2

ESG MSCI

ESG

Medio ambiente

Social

Gobernanza

Polémica

STAAR Surgical Company diseña, desarrolla, fabrica y vende lentes implantables para el ojo y sistemas de colocación de accesorios utilizados para introducir las lentes en el ojo. Estas lentes proporcionan libertad visual a los pacientes, disminuyendo o eliminando la dependencia de gafas o lentes de contacto. La empresa es fabricante de lentes utilizadas en todo el mundo en cirugía correctiva o refractiva. Vende sus productos en aproximadamente 75 países, con distribución directa en Japón, Alemania, España, Estados Unidos, Canadá, Reino Unido y Singapur, con una combinación de distribución directa y distribución independiente en China, Corea, India, Francia, Benelux e Italia. La empresa comercializa y vende lentes ICL para cirugía refractiva destinadas al tratamiento de la miopía (visión corta) como su familia de lentes EVO. La familia de lentes EVO de la empresa incluye sus lentes EVO ICL, EVO+ ICL y EVO Visian ICL. La empresa también comercializa y vende una lente ICL para tratar la hipermetropía (hiperopía), que se llama Visian ICL.

Empleados

1.057

Sector

Equipo médico, suministros y distribución

Agenda

19/02/2025 - Q4 2024 Publicación de resultados

Más información sobre la empresa